Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 10Terminated 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia 19Leukemia, Myeloid, Acute 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Leukemia, Lymphocytic, Chronic, B-Cell 15Multiple Myeloma 13Lymphoma, Non-Hodgkin 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma 13Myelodysplastic Syndromes 12Lymphoma, Mantle-Cell 12Primary Myelofibrosis 11Lymphoma, Follicular 11Hodgkin Disease 11Burkitt Lymphoma 11Lymphoma, B-Cell, Marginal Zone 10Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myeloid, Accelerated Phase 9Congenital Abnormalities 9Neoplasms, Plasma Cell 8Leukemia, Myeloid, Chronic-Phase 8Graft vs Host Disease 8Anemia, Refractory, with Excess of Blasts 8Recurrence 7Myeloproliferative Disorders 7Myelodysplastic-Myeloproliferative Diseases 7Leukemia, Myelomonocytic, Juvenile 7Leukemia, Myelomonocytic, Chronic 7Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7Dendritic Cell Sarcoma, Interdigitating 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Interventions

Cyclophosphamide 14fludarabine 10fludarabine phosphate 8Whole-Body Irradiation 7thymoglobulin 5Thiotepa 5Tacrolimus 5Stem Cell Transplantation 5Standard of Care 5Practice Guidelines as Topic 5Nivolumab 5Granulocyte Colony-Stimulating Factor 5Busulfan 5Azacitidine 5venetoclax 4Radiotherapy 4Mycophenolic Acid 4Methotrexate 4Melphalan 4Filgrastim 4Cytarabine 4Antilymphocyte Serum 4Rituximab 3Mesna 3Leucovorin 3Dexamethasone 3Calcium Dobesilate 3Alemtuzumab 3ruxolitinib 2ceritinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Hematologic Neoplasms × Cyclosporine × Clear all
NCT05579769 2025-10-02

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 10 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT00058825 2016-11-07

HIMSUM

Baylor College of Medicine

Phase 1/2 Terminated
27 enrolled 13 charts
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡